Skip to content

MAPT-derived circTau6 induces tau pathogenesis and neurodegeneration by encoding Tau variants.

Jul 2026 · Molecular Psychiatry · 0 citations · 45 references
Medicine

TL;DR

Findings identify circTau6/cTau4R as a post-transcriptional mechanism that modulates tauopathy and partially recapitulated molecular signatures observed in human tauopathic brains.

View source

Similar papers

Open access Jul 2026

Tau isoform imbalance and aggregation are pathological hallmarks of X-linked dystonia-parkinsonism

It is reported that X-linked Dystonia-Parkinsonism (XDP), caused by a non-coding retrotransposon-associated repeat insertion in TAF1, involves a significant imbalance of tau isoforms and the accumulation of hyperphosphorylated, four-repeat tau in the brain.

C. J. Reyes, Aloysius Domingo, E. Penney et al. · 0 citations
Aug 2026

MAPT splicing modulators reduce 4R tau and rescue tauopathy phenotypes in human neurons and in a mouse model.

Treatment with splicing modulator compounds that promote MAPT exon 10 exclusion reduced 4R tau expression and decreased the accumulation of hyperphosphorylated tau (pTau) and oligomeric and insoluble tau proteoforms, thereby rescuing tau-associated neuronal toxicity.

M. Silva, Hannah Lindmeier, Paolo Pigini et al. · 1 citation · ⚡1
Open access Jul 2026

CELF2 promotes 4R Tau splicing via nuclear clustering and drives cognitive dysfunction in tauopathy models

It is shown that IDR-mediated assembly of the RNA-binding protein CELF2 coordinates tau exon 10 splicing through interactions with NOVA2 and SFPQ, regulating 4 R tau expression and neurological function and impacts tau-related neurodegeneration.

Xin Li, Ishana Syed, Rashmi Adhikari et al. · 0 citations
Sep 2026

Circ_0004801 promotes tau hyperphosphorylation and cognitive impairment in Alzheimer's disease through the miR-7688-5p/TTBK1 axis.

Circ_0004801 acts as an upstream regulator of TTBK1 by sequestering miR-7688-5p, thereby promoting tau hyperphosphorylation and cognitive impairment in AD and may represent a potential target for tau-directed intervention.

Qing-Qing Li, Jie Xiao, Guo-Rong Deng et al. · 0 citations
Open access Aug 2026

Amplification of seeding-competent tau aggregates by PMCA in human and experimental tauopathies

Protein misfolding cyclic amplification (PMCA) is established as an in vitro model for studying the seeded aggregation of tau assemblies, providing a powerful tool to advance research into tau aggregation mechanisms and the development of therapeutic interventions.

Florian Almela, M. Bélondrade, R. Caillierez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.